Trial Profile
Long-acting Naltrexone for Pre-release Prisoners: A Randomized Trial of Mobile Treatment
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 27 Feb 2024
Price :
$35
*
At a glance
- Drugs Naltrexone (Primary)
- Indications Opioid-related disorders
- Focus Therapeutic Use
- 22 Feb 2024 Planned End Date changed from 1 Dec 2024 to 1 Jun 2025.
- 22 Feb 2024 Planned primary completion date changed from 1 Dec 2023 to 1 Feb 2025.
- 17 Feb 2023 Planned End Date changed from 1 Dec 2022 to 1 Dec 2024.